{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:09 23:24:50.411",
            "Expression": "NCT03339973",
            "NStudiesAvail": 430269,
            "NStudiesFound": 1,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 1,
            "FieldList": [
                  "BriefSummary",
                  "BriefTitle",
                  "CentralContactEMail",
                  "CentralContactName",
                  "CentralContactPhone",
                  "CentralContactPhoneExt",
                  "CentralContactRole",
                  "CollaboratorClass",
                  "CollaboratorName",
                  "CompletionDate",
                  "CompletionDateType",
                  "Condition",
                  "ConditionAncestorId",
                  "ConditionAncestorTerm",
                  "ConditionBrowseBranchAbbrev",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "BriefSummary": [
                              "The aim of this clinical trial is to investigate the efficacy (by monitoring the wound size reduction of Peripheral Arterial Occlusive Disease-related clinically relevant ulcers) and safety (by monitoring adverse events) of one dose of allo-APZ2-PAOD administered intramuscularly into an affected lower leg of patients with Peripheral Arterial Occlusive Disease."
                        ],
                        "BriefTitle": [
                              "Allogeneic ABCB5-positive Stem Cells for Treatment of PAOD"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [
                              "INDUSTRY",
                              "INDUSTRY",
                              "OTHER"
                        ],
                        "CollaboratorName": [
                              "FGK Clinical Research GmbH",
                              "Ticeba GmbH",
                              "Granzer Regulatory Consulting & Services"
                        ],
                        "CompletionDate": [
                              "May 15, 2020"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Peripheral Arterial Occlusive Disease"
                        ],
                        "ConditionAncestorId": [
                              "D000014652",
                              "D000002318",
                              "D000050197",
                              "D000001161",
                              "D000016491"
                        ],
                        "ConditionAncestorTerm": [
                              "Vascular Diseases",
                              "Cardiovascular Diseases",
                              "Atherosclerosis",
                              "Arteriosclerosis",
                              "Peripheral Vascular Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC23",
                              "All",
                              "BC14"
                        ],
                        "NCTId": [
                              "NCT03339973"
                        ]
                  }
            ]
      }
}